-
Posted by
Two Blokes Jun 22 -
Filed in
Stock
-
3 views
Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that side effects were mainly mild-to-moderate and other outcome results, including blood sugar levels, were positive.